美国神经外科医师大会系统综述与循证指南:手术治疗WHO II级弥漫性低级别胶质瘤的作用(更新版)
该指南由美国神经外科医师大会制定,更新了手术在成人影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)中作用的循证推荐。推荐手术切除而非观察或活检以改善总生存(III级);推荐在安全可行时实现全切除或次全切除而非仅活检(II级);推荐最大程度安全切除以改善无进展生存和总生存(III级);不推荐5-ALA荧光引导手术改善切除范围(III级)。
要点
- 推荐手术切除而非观察或活检以改善总生存(III级推荐)。
- 推荐在安全可行时实现全切除或次全切除而非仅活检以减少肿瘤进展频率(II级推荐)。
- 推荐最大程度安全切除以改善IDH突变和IDH野生型WHO II级弥漫性胶质瘤的无进展生存和总生存(III级推荐)。
核心结论
- 手术切除被建议用于成人影像学提示WHO II级弥漫性胶质瘤以改善总生存(III级推荐)。
- 推荐在安全可行时实现全切除或次全切除而非仅活检以减少肿瘤进展频率(II级推荐),但需认识到全切除后进展率仍相当高。
- 更大范围切除可改善WHO II级弥漫性胶质瘤患者的总生存(III级推荐)。
- 建议对IDH突变和IDH野生型WHO II级弥漫性胶质瘤最大程度安全切除以改善无进展生存和总生存(III级推荐)。
- 对于1p19q共缺失少突胶质细胞瘤(WHO II级弥漫性胶质瘤),更大范围切除改善总生存的证据不足(III级推荐)。
研究设计与样本
- 美国神经外科医师大会(Congress of Neurological Surgeons)制定的系统综述与循证指南更新版。
- 目标人群为影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人。
- 针对手术切除与观察或活检、最大切除与次全切除/活检、术中MRI和/或超声、癫痫控制、荧光引导手术、清醒开颅和术中定位、术前先进影像等问题给出推荐。
主要发现
- 手术切除较观察或活检改善总生存(III级推荐)。
- 全切除或次全切除较仅活检减少肿瘤进展频率(II级推荐),但全切除后进展率仍相当高。
- 更大范围切除可改善WHO II级弥漫性胶质瘤患者的总生存(III级推荐)。
- 术中MRI被建议用于增加成人WHO II级弥漫性胶质瘤的切除范围(III级推荐)。
- 术中超声被建议用于增加成人WHO II级弥漫性胶质瘤的切除范围(III级推荐)。
关键数值与推荐
- III级推荐:在成人影像学提示WHO II级弥漫性胶质瘤中,建议手术切除而非观察或活检以改善总生存。
- II级推荐:推荐在安全可行时实现全切除或次全切除而非仅活检以减少肿瘤进展频率,但需认识到全切除后进展率仍相当高。
- III级推荐:更大范围切除可改善WHO II级弥漫性胶质瘤患者的总生存。
- III级推荐:建议对IDH突变和IDH野生型WHO II级弥漫性胶质瘤最大程度安全切除以改善无进展生存和总生存。
- III级推荐:对于1p19q共缺失少突胶质细胞瘤(WHO II级弥漫性胶质瘤),更大范围切除改善总生存的证据不足。
临床怎么用
- 对于影像学提示WHO II级弥漫性胶质瘤的成人,建议手术切除而非观察或活检以改善总生存(III级推荐)。
- 推荐在安全可行时实现全切除或次全切除而非仅活检以减少肿瘤进展频率(II级推荐)。
- 建议对IDH突变和IDH野生型WHO II级弥漫性胶质瘤最大程度安全切除以改善无进展生存和总生存(III级推荐)。
- 对于1p19q共缺失少突胶质细胞瘤(WHO II级弥漫性胶质瘤),更大范围切除改善总生存的证据不足(III级推荐)。
- 术中MRI和术中超声被建议用于增加成人WHO II级弥漫性胶质瘤的切除范围(III级推荐)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Target populationAdults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas)QuestionIn adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does surgical resection improve overall survival compared to observation or biopsy?Updated Recommendation from the Prior Version of These Guidelines:Level III: In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), surgical resection is suggested over observation or biopsy to improve overall survival.Question Q2In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does maximal surgical resection improve progression free survival (PFS) and overall survival (OS) compared to subtotal resection/biopsy?Unchanged Recommendations from the Prior Version of These GuidelinesLevel II It is recommended that GTR or STR be accomplished instead of biopsy alone when safe and feasible so as to decrease the frequency of tumor progression recognizing that the rate of progression after GTR is fairly high.Level III Greater extent of resection can improve OS in WHO grade II diffuse gliomas patients. New RecommendationsLevel III: It is suggested that extent of resection be maximized as is safely possible for IDH mutant and IDHwt WHO grade II diffuse gliomas. to improve PFS and OS. Level III: There is insufficient evidence that greater extent of resection of 1p19q codeleted oligodendrogliomas (WHO grade II diffuse gliomas) improves OS Question Q3In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does the addition of intraoperative MRI and/or intraoperative ultrasound during surgery improve extent of resection?Unchanged Recommendation from the Prior Version of These GuidelinesLevel III: The use of intraoperative MRI is suggested to increase the extent of resection for adults with WHO grade II diffuse glioma.New RecommendationLevel III: The use of intraoperative ultrasound is suggested to increase the extent of resection compared to conventional surgery for adults with WHO grade II diffuse glioma.Question 4In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) with seizures, does maximal surgical resection improve seizure control compared to observation or subtotal resection/biopsy?Updated Recommendation from the Prior Version of These GuidelinesLevel III: In adults with imaging consistent with a WHO Grade II diffuse glioma who present with seizure activity, surgical resection of greater than 90% of the lesion, when it can be accomplished safely, is suggested over observation or lesser extent of resection/biopsy to improve seizure control.New Questions and RecommendationsQuestion 5In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas), does use of intraoperative fluorescent guided surgery improve extent of resection?RecommendationLevel III: Intraoperative fluorescent guided surgery with 5-ALA is not suggested to improve the extent of resection for WHO grade II gliomas.Question 6In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does awake craniotomy or other methods of intraoperative mapping increase extent of resection compared to conventional surgery without these techniques?RecommendationLevel III: It is suggested that awake craniotomy and other methods of intraoperative mapping can be used to increase the extent of resection for adults with WHO grade II diffuse glioma.Question 7In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does use of advanced preoperative imaging modalities in the form of fMRI and/or DTI decrease surgical morbidity?RecommendationLevel III: The use of functional MRI and DTI related modalities are suggested to decrease surgical morbidity in adults with WHO grade II diffuse glioma.
引用
- Redjal N, Ziu M, Choi S, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update. J Neurooncol. 2025. PMID: 39806106. doi:10.1007/s11060-024-04871-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。